Oliver I. Strube

Prof. Dr. Oliver I. Strube

Institute for Chemical Engineering, Universität Innsbruck, Innsbruck, Tirol, Austria
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ABAnne Büngeler
Anne Büngeler
BHBenjamin Hämisch
Benjamin Hämisch
Oliver I. StrubeOliver I. Strube
Oliver I. Strube
Research on the supramolecular buildup of eumelanin has gained high momentum in the last years. Several new aspects regarding the involved structures and mechanisms have been established, which has led to a better understanding of the entire process. This review intends to provide a clearly laid-out summary of previous and new findings regarding structures, mechanisms, and controllability. With respect to materials applications, the aspect of controllability is of supreme importance. A focus of this review is therefore set on a novel method with high potential for specific synthesis of various, isolated particle morphologies. Finally, open questions and possibilities for their elucidation are discussed.

9 April 2015 in Biomacromolecules
Verified
Journal Article
Closed access
Oliver I. StrubeOliver I. Strube
Oliver I. Strube
ABAnne Büngeler
Anne Büngeler
WBWolfgang Bremser
Wolfgang Bremser

30 June 2017 in Langmuir
Verified
Journal Article
Closed access
ABAnne Büngeler
Anne Büngeler
BHBenjamin Hämisch
Benjamin Hämisch
KHKlaus Huber
Klaus Huber
WBWolfgang Bremser
Wolfgang Bremser
Oliver I. StrubeOliver I. Strube
Oliver I. Strube

19 August 2021 in Biomacromolecules
Verified
Journal Article
Open access
DHDominik Hense
Dominik Hense
ABAnne Büngeler
Anne Büngeler
FKFabian Kollmann
Fabian Kollmann
MHMarcel Hanke
Marcel Hanke
AOAlejandro Orive
Alejandro Orive
Oliver I. StrubeOliver I. Strube
Oliver I. Strube
The natural blood protein fibrinogen is a highly potent precursor for the production of various biomaterials due to its supreme biocompatibility and cell interaction. To gain actual materials from fibrinogen, the protein needs to undergo fibrillogenesis, which is mostly triggered via enzymatic processing to fibrin, electrospinning, or drying processes. All of those techniques, however, strongly limit the available structures or the applicability of the material. To overcome the current issues of fibrin(ogen) as material, we herein present a highly feasible, quick, and inexpensive technique for self-assembly of fibrinogen in solution into defined, nanofibrous three-dimensional (3D) patterns. Upon interaction with specific anions in controlled environments, stable and flexible hydrogel-like structures are formed without any further processing. Moreover, the material can be converted into highly porous and elastic aerogels by lyophilization. Both of these material classes have never been described before from native fibrinogen. The observed phenomenon also represents the first enzyme-free process of fibrillogenesis from fibrinogen with significant yield in solution. The produced hydrogels and aerogels were investigated via electron microscopy, IR spectroscopy, and fluorescence spectroscopy, which also confirms the native state of the protein. Additionally, their mechanical properties were compared with actual fibrin and unstructured fibrinogen. The structural features show a striking analogy to actual fibrin, both as hydro- and aerogel. This renders the new material a highly promising alternative for fibrin in biomaterial applications. A much faster initiation of fiber formation, exclusion of possible thrombin residuals, and low-cost reagents are great advantages.

8 March 2024 in Green Chemistry
Verified
Journal Article
Open access
PDF file
FOFranziska Obermeier
Franziska Obermeier
DHDominik Hense
Dominik Hense
PSPaul N. Stockmann
Paul N. Stockmann
Oliver I. StrubeOliver I. Strube
Oliver I. Strube
This article provides a comprehensive overview of the current scientific status of monomer and polymer synthesis, as well as the areas of application for (meth)acrylates based on monoterpenes, using the industrially available IBOMA as an example.

23 August 2019 in Langmuir
Verified
Journal Article
Closed access
BHBenjamin Hämisch
Benjamin Hämisch
ABAnne Büngeler
Anne Büngeler
CKCharlotte Kielar
Charlotte Kielar
AKAdrian Keller
Adrian Keller
Oliver I. StrubeOliver I. Strube
Oliver I. Strube
KHKlaus Huber
Klaus Huber